A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Conditions:   Non-small Cell Lung Adenocarcinoma;   Squamous Cell Carcinoma of Lung Interventions:   Drug: SI-B001;   Drug: Docetaxel Sponsor:   Sichuan Baili Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials